Question:
The correct rank order of orientation of sulfonation in toluene is:
The correct rank order of orientation of sulfonation in toluene is:
Updated On: Jul 20, 2024
- 2-methylbenzenesulfonic Acid > 3-methylbenzenesul-fonic acid > 4-methylbenzenesulfonic acid
- 3-methylbenzenesulfonic acid > 2-methylbenzenesul- fonic acid > 4-methylbenzenesulfonic acid
- 3-methylbenzenesulfonic acid > 2-methylbenzenesul-fonic acid > 4-methylbenzenesulfonic acid
- 4-methylbenzenesulfonic acid > 2-methylbenzenesulfonicacid > 3-methylbenzenesulfonic acid
Hide Solution
Verified By Collegedunia
The Correct Option is D
Solution and Explanation
The correct option is (D): 4-methylbenzenesulfonic acid > 2-methylbenzenesulfonicacid > 3-methylbenzenesulfonic acid
Was this answer helpful?
0
0
Top Questions on Resinous drugs
- Etoposide and Teniposide are the semi-synthetic derivatives of:
- GPAT - 2024
- Pharmacognosy
- Resinous drugs
- Etoposide and Teniposide are the semi-synthetic derivatives of:
- GPAT - 2024
- Pharmacognosy
- Resinous drugs
- Pungency of Zingiber officinal e rhizome is due to the presence of :
- GPAT - 2019
- Pharmacognosy
- Resinous drugs
- Identify the false statement about benzodiazepines from the following:
- GPAT - 2019
- Pharmacognosy
- Resinous drugs
- What are known as balsams
- GPAT - 2013
- Pharmacognosy
- Resinous drugs
View More Questions
Questions Asked in GPAT exam
- Choose the correct statement from the following:
(P) Anthraquinone derivatives are generally detected by Borntrager’s test
(Q) Anthrone is yellow colored and soluble in alkali
(R) Anthranol is insoluble in alkali and shows strong red fluorescence
(S) Borntrager’s test gives negative result with Anthranol (Reduced form)- GPAT - 2025
- Introductory Pharmacognosy
- Mirabegron is used in the management of overactive bladder
- How to prepare 200 mL of a 0.15 M sodium hydroxide solution?
- GPAT - 2025
- Pharmaceutical Analysis
- Manufacturing Specification for tooling has been standardized by?
- GPAT - 2025
- Pharmacy Profession & Introduction to Pharmaceuticals
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
View More Questions